Simplex Trading
MLYS icon

Simplex Trading’s Mineralys Therapeutics MLYS Stock Holding History

Simplex Trading’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$817K Sell
32,507
-3,472
-10% -$94.5K ﹤0.01% 2976
2026
Q2 		$971K Buy
35,979
+16,417
+84% +$450K ﹤0.01% 2812
2026
Q1 		$530K Buy
19,562
+14,760
+307% +$433K ﹤0.01% 3187
2025
Q4 		$174K Buy
4,802
+379
+9% +$15.2K ﹤0.01% 4366
2025
Q3 		$167K Buy
+4,423
New +$95.7K ﹤0.01% 5151
2025
Q2 		– Sell
-25,543
Closed -$370K – 9327
2025
Q1 		$405K Buy
25,543
+25,206
+7,480% +$290K ﹤0.01% 3620
2024
Q4 		$4K Buy
337
+33
+11% +$432 ﹤0.01% 7761
2024
Q3 		$3K Buy
+304
New +$3.68K ﹤0.01% 7856

Other funds holding MLYS

Catalys Pacific
Catalys Pacific Tokyo, Japan $210M AUM 33.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Andera Partners
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Simplex Trading's MLYS Position: Q3 2026 in Review

Simplex Trading reduced its Mineralys Therapeutics (MLYS) stake by 9.7% in Q3 2026, selling an estimated $94.5K and leaving 32,507 shares worth $817K. The position accounts for ﹤0.01% of the portfolio, ranked #2976.

Simplex Trading first reported a position in MLYS in Q3 2024 and has held it in 8 quarters since. The position peaked at $971K in Q2 2026. 116 funds tracked by Wall St. Rank hold MLYS as of Q3 2026.

  • Simplex Trading held 32,507 shares of Mineralys Therapeutics worth $817K as of Q3 2026.
  • Simplex Trading sold 3,472 Mineralys Therapeutics shares in Q3 2026, an estimated $94.5K.
  • Mineralys Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #2976 holding.
  • Simplex Trading first reported a position in Mineralys Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Simplex Trading's Mineralys Therapeutics position peaked at $971K in Q2 2026.
  • 116 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.